Amphastar Pharmaceuticals: Q4 Earnings Insights

Amphastar Pharmaceuticals AMPH reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Amphastar Pharmaceuticals beat estimated earnings by 13.51%, reporting an EPS of $0.42 versus an estimate of $0.37.

Revenue was up $24.97 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.22 which was followed by a 4.06% increase in the share price the next day.

Here's a look at Amphastar Pharmaceuticals's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.